Adlercreutz H - Search Results

1

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer.

Lønning PE, Helle SI, Johannessen DC, Ekse D, Adlercreutz H. Lønning PE, et al. Among authors: adlercreutz h. Breast Cancer Res Treat. 1996;39(3):335-41. doi: 10.1007/BF01806162. Breast Cancer Res Treat. 1996. PMID: 8877014

2

Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.

Lønning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA, Tally M, Ekse D, Fotsis T, Anker GB, Hall K. Lønning PE, et al. Among authors: adlercreutz h. Clin Endocrinol (Oxf). 1995 Jan;42(1):23-30. doi: 10.1111/j.1365-2265.1995.tb02594.x. Clin Endocrinol (Oxf). 1995. PMID: 7534218

3

Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients.

Lønning PE, Johannessen DC, Lien EA, Ekse D, Fotsis T, Adlercreutz H. Lønning PE, et al. Among authors: adlercreutz h. J Steroid Biochem Mol Biol. 1995 May;52(5):491-6. doi: 10.1016/0960-0760(94)00189-s. J Steroid Biochem Mol Biol. 1995. PMID: 7748814

4

Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.

Johannessen DC, Adlercreutz H, Fotsis T, Lønning PE. Johannessen DC, et al. Among authors: adlercreutz h. Br J Cancer. 1993 Aug;68(2):393-8. doi: 10.1038/bjc.1993.347. Br J Cancer. 1993. PMID: 8135918 Free PMC article.

5

Aromatase inhibitor development for treatment of breast cancer.

Masamura S, Adlercreutz H, Harvey H, Lipton A, Demers LM, Santen RJ, Santner SJ. Masamura S, et al. Among authors: adlercreutz h. Breast Cancer Res Treat. 1995;33(1):19-26. doi: 10.1007/BF00666067. Breast Cancer Res Treat. 1995. PMID: 7749129 Review.

6

Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.

Helin HJ, Isola JJ, Helle MJ, Adlercreutz H. Helin HJ, et al. Among authors: adlercreutz h. Breast Cancer Res Treat. 1988 Sep;12(1):67-73. doi: 10.1007/BF01805742. Breast Cancer Res Treat. 1988. PMID: 3196886

7

Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy.

Berstein LM, Tsyrlina EV, Kolesnik OS, Gamajunova VB, Adlercreutz H. Berstein LM, et al. Among authors: adlercreutz h. J Steroid Biochem Mol Biol. 2000 Mar;72(3-4):143-7. doi: 10.1016/s0960-0760(00)00038-8. J Steroid Biochem Mol Biol. 2000. PMID: 10775805

8

Plasma levels of enterolactone and percentage mammographic density among postmenopausal women.

Stuedal A, Gram IT, Bremnes Y, Adlercreutz H, Veierød MB, Ursin G. Stuedal A, et al. Among authors: adlercreutz h. Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2154-9. doi: 10.1158/1055-9965.EPI-05-0116. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16172225

9

Effect of diet on excretion of estrogens in pre- and postmenopausal women.

Goldin BR, Adlercreutz H, Dwyer JT, Swenson L, Warram JH, Gorbach SL. Goldin BR, et al. Among authors: adlercreutz h. Cancer Res. 1981 Sep;41(9 Pt 2):3771-3. Cancer Res. 1981. PMID: 7260944

10

Diets and hormonal levels in postmenopausal women with or without breast cancer.

Aubertin-Leheudre M, Hämäläinen E, Adlercreutz H. Aubertin-Leheudre M, et al. Among authors: adlercreutz h. Nutr Cancer. 2011;63(4):514-24. doi: 10.1080/01635581.2011.538487. Nutr Cancer. 2011. PMID: 21500098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

478 results

Search Page